Ignite Creation Date:
2025-12-24 @ 7:57 PM
Ignite Modification Date:
2025-12-25 @ 5:31 PM
Study NCT ID:
NCT03369704
Status:
COMPLETED
Last Update Posted:
2021-01-05
First Post:
2017-11-14
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Study of Efficacy and Safety of Omalizumab in Severe Japanese Cedar Pollinosis Adult and Adolescent Patients
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-12-15
Start Date Type:
ACTUAL
Primary Completion Date:
2018-05-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-10-20
Completion Date Type:
ACTUAL
First Submit Date:
2017-11-14
First Submit QC Date:
None
Study First Post Date:
2017-12-12
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2019-04-05
Results First Submit QC Date:
None
Results First Post Date:
2019-11-04
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-12-09
Last Update Post Date:
2021-01-05
Last Update Post Date Type:
ACTUAL